» Articles » PMID: 36077689

Hypermethylation of PRKCZ Regulated by E6 Inhibits Invasion and EMT Via Cdc42 in HPV-Related Head and Neck Squamous Cell Carcinoma

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Sep 9
PMID 36077689
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To study the role of target genes with aberrant DNA methylation in HPV+ HNSCC.

Methods: A HumanMethylation450 BeadChip array (Illumina) was used to identify differentially methylated genes. CCK-8, flow cytometry, wound healing, and cell invasion assays were conducted to analyze the biological roles of PRKCZ. Western blot, qRT-PCR, immunohistochemistry, and animal studies were performed to explore the mechanisms underlying the functions of PRKCZ.

Results: We selected PRKCZ, which is associated with HPV infection, as our target gene. PRKCZ was hypermethylated in HPV+ HNSCC patients, and PRKCZ methylation status was negatively related to the pathological grading of HNSCC patients. Silencing PRKCZ inhibited the malignant capacity of HPV+ HNSCC cells. Mechanistically, HPV might promote DNMT1 expression via E6 to increase PRKCZ methylation. Cdc42 was required for the PRKCZ-mediated mechanism of action, contributing to the occurrence of epithelial-mesenchymal transition (EMT) in HPV+ HNSCC cells. In addition, blocking PRKCZ delayed tumor growth in HPV16-E6/E7 transgenic mice. Cdc42 expression was decreased, whereas E-cadherin levels increased.

Conclusion: We suggest that PRKCZ hypermethylation induces EMT via Cdc42 to act as a potent tumor promoter in HPV+ HNSCC.

Citing Articles

The Role of the Cytoskeletal Regulatory Protein, Mammalian Enabling Protein (Mena), in Invasion and Metastasis of HPV16-Related Oral Squamous Cell Carcinoma.

Guo Z, Xie L, Cui H, Yang X, Qi H, Yu M Cells. 2024; 13(23).

PMID: 39682720 PMC: 11640048. DOI: 10.3390/cells13231972.


Genetic polymorphism in untranslated regions of PRKCZ influences mRNA structure, stability and binding sites.

Mustafa A, Shabbir M, Badshah Y, Khan K, Abid F, Trembley J BMC Cancer. 2024; 24(1):1147.

PMID: 39272077 PMC: 11401371. DOI: 10.1186/s12885-024-12900-8.

References
1.
Lai K, Liu C, Chang K, Lee T . Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells. Oncogene. 2012; 32(32):3686-97. DOI: 10.1038/onc.2012.384. View

2.
Hall A . Rho family GTPases. Biochem Soc Trans. 2012; 40(6):1378-82. DOI: 10.1042/BST20120103. View

3.
Stransky N, Egloff A, Tward A, Kostic A, Cibulskis K, Sivachenko A . The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333(6046):1157-60. PMC: 3415217. DOI: 10.1126/science.1208130. View

4.
Chow L . Head and Neck Cancer. N Engl J Med. 2020; 382(1):60-72. DOI: 10.1056/NEJMra1715715. View

5.
Cohen E, Lingen M, Zhu B, Zhu H, Straza M, Pierce C . Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res. 2006; 66(12):6296-303. DOI: 10.1158/0008-5472.CAN-05-3139. View